Hair Loss Profiles and Ritlecitinib Efficacy in Patients with Alopecia Areata: Post Hoc Analysis of the ALLEGRO Phase 2b/3 Study
ConclusionDistinct and clinically relevant hair loss profiles were identified in ALLEGRO-2b/3 participants. Ritlecitinib was efficacious compared with placebo, independent of hair loss profile at baseline.Trial registrationClinicalTrials.gov identifier, NCT03732807.Graphical abstract
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Alopecia | Alopecia Areata | Alopecia Totalis | Alopecia Universalis | Dermatology | Skin | Study